A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
12/1992
12/21/1992	CA2111470A1 Accelerated wound healing
12/19/1992	CA2071395A1 Coccidiosis poultry vaccine
12/18/1992	CA2069382A1 Imidazodiazepine
12/16/1992	CN1019492B Imidazodiazepine derivatives
12/15/1992	CA1311415C Lipid vesicles formed of surfactants and steroids
12/10/1992	WO1992021337A1 Methods of treating injury to the central nervous system
12/09/1992	EP0516792A1 Heparin derivatives
12/08/1992	US5169858 Anti-tumor compositions containing the reactive product of benzaldehyde or salicylaldehyde with penicillamine and method of use thereof
12/08/1992	US5169626 Low residue antiperspirant sticks
12/02/1992	EP0313561B1 Compositions used in permanent structure altering of hair
12/02/1992	CN1066588A Fluoro carbon emulsion and its production process
12/01/1992	WO1992021677A1 bibNUCLIDINE DERIVATIVES
12/01/1992	WO1992021352A1 USE OF 1-(β-D-ARABINOFURANOSYL)-5-PROPYNYLURACIL FOR LOWERING SERUM CHOLESTEROL
12/01/1992	CA2088264A1 Nucleoside derivative
12/01/1992	CA1310914C Use of 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid or its salts for the protection of hair against atmospheric attack and particularly against light, and process for the protection of hair using this compound
11/1992
11/30/1992	WO1992021359A1 Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof
11/26/1992	WO1992020344A1 Antiviral combinations containing nucleoside analogs
11/26/1992	WO1992020341A1 Method and composition for ameliorating the adverse effects of aging
11/26/1992	WO1992013516A3 Improved antiperspirant formulations
11/25/1992	EP0515312A2 Pharmaceutical composition containing terbinafine as an anti-mycotic agent
11/25/1992	EP0514491A1 Light-resistant filtering cosmetic composition containing a uv-a filter and an alkyl beta, beta-diphenylacrylate or an alkyl alpha-cyano-beta, beta-diphenylacrylate.
11/24/1992	US5166331 Antibiotics, viricides, antiinflammatory agents, wound healing agents, cytostatics, anesthetics, cholinergics or adrenergics
11/24/1992	US5165932 Therapeutical compositions against psoriasis
11/24/1992	US5165427 Cysteinamide--containing permanent wave composition and method
11/24/1992	CA1310637C Epipodophyllotoxin glucoside 4'-phosphate derivatives
11/24/1992	CA1310585C COSMETIC APPLICATION OF POLYSILOXANES HAVING A .beta.-CETOESTER FUNCTION, AND COMPOSITIONS PRODUCED
11/19/1992	EP0514067A1 Cosmetic composition
11/19/1992	EP0513917A1 Antiviral combinations containing nucleoside analogs
11/19/1992	EP0513671A1 Commiphora mukul extracts and therapeutical applications thereof
11/19/1992	EP0513513A1 Use of glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy
11/19/1992	EP0513200A1 Method and compositions for the synthesis of bch-189 and related compounds
11/19/1992	EP0513183A1 Cosmetic compositions.
11/17/1992	US5164377 Sulphated glycosaminoglycuronan with antithrombotic activity
11/17/1992	CA2087158A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/12/1992	WO1992019640A1 A substance for lowering high cholesterol level in serum and a method for preparing the same
11/12/1992	WO1992019249A1 Compositions for the prevention and/or treatment of pathological processes
11/12/1992	CA2102207A1 Compositions for the prevention and/or treatment of patholigical processes
11/11/1992	WO1992000749A1 Anti-herpes virus and cytomegalovirus oligomers
11/11/1992	EP0512343A2 Amino acid derivatives and their use as anti-viral agents
11/11/1992	EP0512292A2 Composition for disclosing dental plaque containing cobalamin
11/11/1992	EP0409862B1 Topical preparations
11/11/1992	EP0299975B1 Composition for arresting angiogenesis and capillary, cell or membrane leakage
11/11/1992	CA2068366A1 Microcapsule composition and process
11/10/1992	US5162346 Pharmaceutical composition comprising flupirtine and its use to combat muscular tension
11/07/1992	CA2067989A1 Composition for disclosing dental plaque
11/04/1992	EP0511703A2 Pharmaceutical composition, containing sucralfate and carrageenan, useful for gastroenterology
11/03/1992	WO1992019246A1 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
11/03/1992	US5160739 Cosmetic composition
11/03/1992	US5160738 Emollient for skin or hair that does not contain petrolatum, blend of two polyol fatty acid esters, polyol is a sugar or sugar alcohol
11/03/1992	CA2102120A1 Use of a 1,3-oxathlolan derivative for the treatment of hepatitis b infection
11/03/1992	CA1309671C Monoclonal antibodies to cyclosporins
11/03/1992	CA1309663C Method and composition for treatment and prevention of pseudofolliculitis barbae
10/1992
10/29/1992	WO1992018110A1 Process for conditioning of water-soluble substances
10/29/1992	WO1992018105A1 Improvements in pharmaceutical compositions
10/29/1992	WO1992018004A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs
10/29/1992	WO1992014743A3 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/29/1992	CA2102221A1 Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
10/28/1992	EP0510356A1 Polyethylene glycol protein conjugates
10/28/1992	EP0510151A1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and anti-microbial agent.
10/28/1992	CN1065661A Heterocyclic compounds
10/28/1992	CN1018845B 病毒疫苗 Virus vaccine
10/27/1992	US5158773 Retinoid esters
10/27/1992	CA1309558C D-gl conjugate therapy
10/27/1992	CA1309349C Anti-ulcer-remedy containing tetrahydroisoquinoline derivatives
10/26/1992	CA2067070A1 Pharmaceutical compositions useful for gastroenterology
10/22/1992	DE4112464A1 Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial Improved sustained-release systems for the zeitverzoegerte medical and / or biological reusable materials from a depot-traegermaterial
10/21/1992	EP0509974A1 Pyrrolo[2,3-b]pyridines having therapeutic activity and a process for the preparation thereof
10/21/1992	EP0509906A1 Complexes of Polyadenylic acid with polyuridylic acid for the treatment of AIDS
10/21/1992	EP0509470A2 Therapeutical compositions having anti-HIV activity consisting of 2',3'-didesoxyadenosine and substances inhibiting adenosine deaminase
10/21/1992	EP0509401A1 Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
10/21/1992	CN1065465A Polyethylene protein conjugates
10/20/1992	CA2066395A1 Therapeutical compositions having anti-hiv activity consisting of didesoxy adenosine and substances inhibiting adenosine deaminase
10/20/1992	CA2066059A1 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
10/18/1992	WO1992018108A1 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material
10/18/1992	CA2108680A1 Improved retard systems for the sustained release of medicinal and/or biological valuable materials from a depot carrier material
10/15/1992	WO1992017212A1 Improvements in or relating to contrast agents
10/14/1992	EP0508969A1 Process for conditioning of water-soluble substances
10/13/1992	WO1992018107A1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
10/13/1992	US5155133 Antiarrhythmic compounds and pharmaceutical compositions and methods thereof
10/07/1992	CN1065065A Process for preparing 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/07/1992	CN1065063A 1-biphenylmethyl imidazole derivatives, their preparation and their therapeutic use
10/07/1992	CN1018548B Carboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions containing them
10/06/1992	US5153312 Respiratory system disorders
10/06/1992	US5153192 For controlling intraocular pressure
09/1992
09/30/1992	EP0505868A2 N-Acyl-alpha-aminoacids derivatives
09/30/1992	CN1064861A Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use
09/30/1992	CN1064811A Method of and preparations for treating musculeskeletal and neural disorders
09/28/1992	WO1992017477A1 New active compounds
09/28/1992	CA2106880A1 Active compounds
09/27/1992	CA2061661A1 N-acyl-.alpha.-amino derivatives
09/23/1992	EP0504372A1 Cosmetic technology
09/23/1992	EP0504363A1 PURIFIED IgG ANTIBODIES
09/23/1992	EP0226591B1 Anti-tumor compositions containing the reaction product of a cytotoxic aldehyde with penicillamine and their use for the manufacture of medicaments
09/23/1992	CN1064682A Heterocyclic compounds
09/17/1992	WO1992015314A1 Pharmaceutical compositions for the treatment of skin disorders
09/17/1992	WO1992015309A1 Antiviral nucleoside combination
09/17/1992	CA2439322A1 Therapeutic nucleosides
09/17/1992	CA2105073A1 Pharmaceutical compositions for the treatment of skin disorders
09/16/1992	EP0504112A2 Pharmaceutical aerosol formulations
09/16/1992	EP0503785A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use

1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 295